Cipla & Kemwell Biopharma extend their JV for developing, manufacturing & commercializing biosimilars
The joint venture will leverage Cipla and Kemwell’s complementary strengths for end-to-end product development, clinical development, regulatory filings, manufacturing and commercialisation of biopharmceutical products